drugset / Trial / NCT00529438
RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies
NaSingle-groupOpen-labelTreatment
Summary
This study assesses the tolerability, safety, efficacy and pharmacokinetics of Bardoxolone methyl (RTA 402) in advanced solid tumors and lymphoid malignancies.
Timeline
- Start
- 2006-04-30
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bardoxolone methyl | Small molecule | — | Oral |